| abstract |
Use of the peptide identified as SEQ ID NO: 1 for manufacturing a drug which induces antitumor and antiviral immunity mediated by immunogenic cell death. The invention also provides a method for treating cancer or viral infections, characterised in that it administers, to an individual in need, a therapeutically effective amount of a drug for the induction of antitumor and antiviral immunity mediated by immunogenic cell death, the drug comprising said synthetic peptide. The invention also relates to a pharmaceutical combination comprising the peptide identified as SEQ ID NO: 1 and a vaccine for cancer immunotherapy, which results in a more effetive immunotherapeutic approach to this disease. |